CytomX Therapeutics (CTMX) Goodwill & Intangibles (2014 - 2026)

CytomX Therapeutics' Goodwill & Intangibles history runs 13 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Goodwill & Intangibles fell 9.76% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 9.76% YoY) and the FY2025 annual result came in at $1.4 million, down 9.46% from the prior year.
• Goodwill & Intangibles was $1.3 million for Q1 2026 at CytomX Therapeutics, down from $1.4 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $1.9 million in Q1 2022 and bottomed at $1.3 million in Q1 2026.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles retreated 7.02% — and 2026, when it decreased 9.76%.
• CytomX Therapeutics' Goodwill & Intangibles stood at $1.8 million in 2022, then slipped by 8.0% to $1.7 million in 2023, then decreased by 8.7% to $1.5 million in 2024, then dropped by 9.46% to $1.4 million in 2025, then decreased by 2.67% to $1.3 million in 2026.
• Business Quant data shows CTMX's Goodwill & Intangibles at $1.3 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.